STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development expense related party	$ 28,511	$ 16,156
Research and Development - Related Party	1,000	750
General and administrative	12,751	4,668
Total operating expenses	42,262	21,574
Loss from operations	(42,262)	(21,574)
Interest income	1,351	69
Other expense	(45)	(38)
Net loss	(40,956)	(21,543)
Accretion to redemption value and cumulative dividends on preferred stock	(1,820)	(6,515)
Net loss attributable to common stockholders	$ (42,776)	$ (28,058)
Net loss per share attributable to common stockholders, basic	$ (2.79)	$ (10.64)
Net loss per share attributable to common stockholders, diluted	$ (2.79)	$ (10.64)
Weighted-average number of shares used in computing net loss per share, basic	15,340,134	2,638,197
Weighted-average number of shares used in computing net loss per share, diluted	15,340,134	2,638,197
Other comprehensive income (loss):
Unrealized loss on investments	$ (347)	$ (27)
Comprehensive loss	$ (41,303)	$ (21,570)